News and Press Releases

Contact Veristat Now


Request A Proposal

Contact Us

Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With Appointment of Mark Chang

June 15, 2016

Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting

 

SOUTHBOROUGH, MA – June 15, 2016Veristat, a full service Clinical Research Organization (CRO), announced that it has strengthened its statistical consulting and adaptive design expertise with the appointment of Mark Chang, PhD to the newly created position of Senior Vice President of Strategic Statistical Consulting.   Dr. Chang will help clients evaluate and implement strategic, operational and technical efficiencies to advance products through the clinical trial and regulatory submission process.

Read More

Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology

May 1, 2016

SOUTHBOROUGH, MA – May 2, 2016Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its clinical research offerings into Europe through the acquisition of UK-based CRO, Spero Oncology.   Spero Oncology is a UK-based CRO specializing in providing clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand. With the acquisition of Spero Oncology, Veristat now offers its clients full clinical operations support in Europe including feasibility studies, legal representation in the European Union, Clinical Monitoring, Project Management, Protocol Writing and Regulatory Strategy.

Read More

Veristat Ranked #35 on Boston Business Journal’s “Fast 50” List, the Top 50 Fastest Growing Private Companies in Massachusetts

April 24, 2016

Veristat Recognized as One of the Top 50 Fastest-Growing Private Companies in Massachusetts

Veristat, a full service Clinical Research Organization (CRO), announced today that it has been recognized as one of the top 50 fastest-growing private companies in Massachusetts, taking the #35 slot.   According to Privco[i], there are over 4,000 private firms operating in Massachusetts today.

Read More

Veristat Named as One of the Fastest Growing Private Companies in Massachusetts by Boston Business Journal

April 6, 2016

Veristat joins the Boston Business Journal’s 2016 Fast 50 (Formerly Pacesetters) list.   This is the list of the fastest growing private companies in Massachusetts.

Read More

Veristat Strengthens Senior Management Team: Appoints Faith Haines Kolb as Vice President, Biometrics

March 8, 2016

SOUTHBOROUGH, MA – March 08, 2016Veristat, a full service Clinical Research Organization (CRO), announced today the appointment of Faith Haines Kolb to the newly created position Vice President of Biometrics.   Faith joins Veristat with over 20 years of experience leading operational teams and large-scale projects during periods of rapid growth and international expansion for both large and small CROs.  As Vice President of Biometrics, Faith will lead and continue to grow the Biostatistics and Programming teams, as well as the Data Management and Data Standards groups at Veristat.

Read More

Veristat participates in Cycle for Survival 2016 and raises over $20,000 to fund rare cancer research.

March 1, 2016

Veristat Raises over $20,000 to Support Rare Cancer Research

On Saturday, February 27th, Team Veristat JOINED THE BATTLE with Cycle for Sur­vival 2016!  Team Veristat had riders at both the Boston, MA and Palo Alto, CA events.   In Boston, over 900 riders participated in this amazing, fun and inspiring event!  Across the country in 2016 alone, over twenty million dollars has been raised to fund rare cancer research.

Read More

Veristat Supports and Honors Rare Disease Day 2016

February 10, 2016

Read More

Veristat Rides in Cycle for Survival 2016 Event to Raise Money to Fight Rare Cancers

January 18, 2016

Veristat Supports the Upcoming Boston Cycle for Survival Event   
Join Veristat in the Fight Against Rare Cancers:  Donate Today!

Read More

Veristat and Cidara Therapeutics Collaborate with a Preferred Provider Agreement

January 12, 2016

Veristat to Assist Cidara with Its Trials for Novel Echinocandin Antifungal CD101

Read More

Happy Holiday Wishes & Giving from Veristat

December 21, 2015

Read More